CIK 0001863127 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831476348
- Phone
- (619) 728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- Open-market buys, last 90 days
- $20,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 72 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-15 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase · Pre-Funded Warrants (Right to Buy) | +9,078,529 | $22.03 | $200.0M | 11,616,986 |
| 2026-09-15 | Harris Todd President and CEO | Grant or award | +864 | $9.13 | $8K | 1,438,495 |
| 2026-09-15 | Rueb Yuliya Vice President, Finance (PAO) | Grant or award | +2,925 | $9.13 | $27K | 11,258 |
| 2026-09-15 | Fuhrman Alan Chief Financial Officer | Grant or award | +951 | $9.13 | $9K | 37,115 |
| 2026-09-09 | Verjee Rehan Director | Purchase | +971.89 | $20.58 | $20K | 971.89 |
| 2026-05-28 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +13,160 | 13,160 | ||
| 2026-05-28 | Verjee Rehan Director | Grant or award · Stock Option (Right to Buy) | +13,160 | 13,160 | ||
| 2026-05-28 | Moran Susan Director | Grant or award · Stock Option (Right to Buy) | +13,160 | 13,160 | ||
| 2026-05-28 | Simson Jake Director | Grant or award · Stock Option (Right to Buy) | +13,160 | 13,160 | ||
| 2026-05-28 | Gulfo Adele M. Director | Grant or award · Stock Option (Right to Buy) | +13,160 | 13,160 | ||
| 2026-05-28 | MORE ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +13,160 | 13,160 | ||
| 2026-05-28 | Rothenberg Stephen Michael Director | Grant or award · Stock Option (Right to Buy) | +13,160 | 13,160 | ||
| 2026-05-05 | Warner Douglas J Chief Medical Officer | Grant or award | +25,000 | 25,000 | ||
| 2026-05-05 | Warner Douglas J Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2026-05-05 | Fuhrman Alan Chief Financial Officer | Grant or award | +20,000 | 36,164 | ||
| 2026-05-05 | Fuhrman Alan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +67,000 | 67,000 | ||
| 2026-05-05 | Harris Todd President and CEO | Grant or award | +79,000 | 1,437,631 | ||
| 2026-05-05 | Harris Todd President and CEO | Grant or award · Stock Option (Right to Buy) | +265,000 | 265,000 | ||
| 2026-05-05 | Ashar Bhavesh Chief Operating Officer | Grant or award | +15,013 | 15,013 | ||
| 2026-05-05 | Ashar Bhavesh Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +50,295 | 50,295 |
Page 1 of 9 · 170 trades